DTL
CTKB icon

Dynamic Technology Lab’s Cytek Biosciences CTKB Stock Holding History

Dynamic Technology Lab’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,778
Closed -$64.6K – 754
2026
Q1 		$64.6K Sell
14,778
-29,496
-67% -$139K 0.01% 809
2025
Q4 		$224K Buy
44,274
+9,155
+26% +$42.5K 0.05% 588
2025
Q3 		$122K Sell
35,119
-10,595
-23% -$39.8K 0.02% 716
2025
Q2 		$155K Buy
45,714
+32,427
+244% +$108K 0.02% 827
2025
Q1 		$53K Sell
13,287
-11,136
-46% -$57.7K 0.01% 928
2024
Q4 		$159K Sell
24,423
-3,580
-13% -$21.3K 0.03% 790
2024
Q3 		$155K Buy
28,003
+4,533
+19% +$25.7K 0.02% 912
2024
Q2 		$131K Buy
23,470
+6,524
+38% +$39.2K 0.01% 836
2024
Q1 		$114K Buy
+16,946
New +$134K 0.01% 961
2023
Q2 		– Sell
-13,581
Closed -$125K – 1065
2023
Q1 		$125K Buy
+13,581
New +$146K 0.01% 956

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dynamic Technology Lab's CTKB Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Cytek Biosciences (CTKB) in Q2 2026, closing a stake of 14,778 shares — an estimated $64.6K sold.

Dynamic Technology Lab first reported a position in CTKB in Q1 2023 and held it in 10 quarters. The position peaked at $224K in Q4 2025. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Dynamic Technology Lab reported no remaining Cytek Biosciences position as of Q2 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 14,778 Cytek Biosciences shares in Q2 2026, an estimated $64.6K.
  • Dynamic Technology Lab first reported a position in Cytek Biosciences in Q1 2023 and held it in 10 quarters.
  • Dynamic Technology Lab's Cytek Biosciences position peaked at $224K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.